Both F10503LO1 and F21010RS1 decreased the content of phospho-AKT, at the time that activate PARP and caspase 9 and 3, all mechanisms compatible with the observed loss of viability of the melanoma cells. This evidence concerns the gene CASP9 and melanoma.